New roles aim to streamline operations and boost growth
Staar Surgical announced a major leadership restructuring to enhance focus on revenue growth and operational efficiency following recent layoffs.
- Warren Foust, previously COO, now assumes the expanded role of President and COO, overseeing sales, manufacturing, and operations, with several key executives now reporting to him.
- Magda Michna is promoted to Chief Development Officer, adding R&D and quality to her oversight of clinical, regulatory, and medical affairs. Keith Holiday, former CTO and head of R&D, will exit the company.
- Deborah Andrews steps in as interim CFO, replacing Patrick Williams, who will assist during a three-month transition period.
CEO Steve Farrell, newly appointed, said the restructuring is the first step in positioning the company for stronger performance and increased shareholder value.
Follow MEDWIRE.AI for leadership shifts and medtech market insights.
